Navigation Links
Intellikine Completes $51 Million Financing
Date:7/8/2009

ships to deliver the best medicines for patients and the greatest value for our investors."

"Intellikine has rapidly assembled one of the best pipelines against a very important class of drug targets," commented Markus Goebel, Managing Director, Novartis Venture Funds. "I am very much looking forward to working with the management team and board to build the company and, in particular, to establish clinical proof of concept for the company's lead programs."

About Intellikine

Intellikine is a leader in the discovery and development of novel, small molecule therapies targeting the PI3K/mTOR pathway for the treatment of cancer, inflammation and autoimmune diseases. Intellikine has discovered multiple classes of proprietary compounds that selectively target isoforms of the PI3K pathway. The company's most advanced compound, INK128, a potent and selective TORC1/2 inhibitor with exceptional drug-like properties is scheduled to enter Phase I clinical evaluation within 12 months. Intellikine is developing PI3K-delta/gamma dual-selective inhibitors for the treatment of cancer, inflammatory and respiratory diseases and PI3K-alpha/beta selective inhibitors for the treatment of solid tumor malignancies as well as other isoform-selective inhibitors of the PI3K/mTOR pathway. Intellikine is a private company based in La Jolla, California. For more information, please visit the company's website at www.intellikine.com.


'/>"/>
SOURCE Intellikine, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action
2. Verenium Completes Amendment to 8% Senior Convertible Notes
3. Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
4. Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
5. Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
6. EFT BioTech Holdings, Inc.s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait
7. Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma
8. Cordex Completes Production of ATPace(TM) Clinical Trial Material
9. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
10. Brooks Instrument Completes Acquisition of Celerity's Instrumentation Division
11. Sinovac Completes Construction of H1N1 Virus Seed Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 DuPont welcomes 48 of ... annual DuPont National AgriScience Teachers Ambassador Academy this week ... Chestertown, Md. , The NATAA “Ag Academy” ... is a special project of the National FFA ... Educators (NAAE) . The highly recommended agriscience teachers, ...
(Date:6/18/2013)... 18, 2013  regulated information — Global biopharmaceutical company ... today announced the launch of a new Pledge campaign ... The Pledge empowers the millions of ... make a personal commitment to demand more: greater understanding ... team and additional partial-onset seizure control.  More information is ...
(Date:6/18/2013)... ZIONA, Israel , June 18, ... of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative ... systems, announced today that the company has been granted a ... is indicated in the US and Europe ... US Patent number 8,410,176 B2 is titled Intermediate ...
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
Breaking Biology Technology:DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... KERX ) will hold a conference call on ... the fourth quarter and year-end 2007,financial results and business ... Officer of the Company, will host the call. Keryx ... press release to be,issued prior to the call., ...
... With two successful,international product launches, Swedish ... phase. The share issue will strengthen,Cellectricon,s financial ... product,launches in 2008-2009. These products have been ... companies to meet the,industry,s increasing demand for ...
... Feb. 21 Human Genome,Sciences, Inc. (Nasdaq: HGSI ... Executive Officer of Trevena, Inc., a privately held,drug discovery ... Directors.,Prior to joining Trevena, Dr. Gowen spent 15 years ... management positions in drug,discovery and development, and led the ...
Cached Biology Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST 2Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors 2Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors 3Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors 4
(Date:6/19/2013)... MedNet Solutions , a global life ... is pleased to announce its participation in the 2013 ... Boston .  This represents the 10 ... cloud-based eClinical solutions, has exhibited at this premier industry ... iMedNet™ EDC , MedNet,s latest, easy-to-use eClinical technology ...
(Date:6/19/2013)... how pearls form into the most perfectly spherical large ... are proposing in a new study. It appears in ... Laureate Irving Langmuir. , Julyan Cartwright, Antonio G. Checa ... and highly prized pearls have perhaps the most perfectly ... nature that are visible without a microscope. Pearls develop ...
(Date:6/19/2013)... 2012, the European Medicines Agency (EMA) approved the ... ever gene therapy for clinical use in the ... developed AAV-LPL S447X for the treatment of a ... (LPLD) which affects approximately one or two out ... life-threatening inflammations of the pancreas. Afflicted individuals carry ...
Breaking Biology News(10 mins):MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2No danger of cancer through gene therapy virus 2
... Directorate,s Fifth Annual University Summit will be held ... 1 2011. This event is DHS,s flagship ... scientists, government officials and industry. The Summit ... research areas with DHS components, industry, first responders, ...
... Ertuğrul zbudak, Ph.D. , assistant professor of genetics ... Yeshiva University, has won a 2011 Sloan Research Fellowship ... genetic causes of vertebral malformations that occur during embryonic development ... disfigurement, and back and neck pain. This year, the ...
... A research team led by Edward Yu of Iowa State University ... the three-part system that pumps toxins from bacteria and allows them ... 24 issue of the journal Nature . The paper ... pump that recognizes and removes heavy metal toxins from bacteria. A ...
Cached Biology News:DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 2DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 3DHS Science and Technology Directorate's science conference: 'Catastrophes and Complex Systems' 4Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship 2Iowa State, Ames Lab researchers describe the pump that bacteria use to resist drugs 2
... from non-demolished blood that is ... The donors are not medicated ... maintained on an antibiotic free ... : 85 mg/ml (by Refractometry).Strain: ...
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
... CyScribe First-Strand cDNA Labeling Kit ... reactions. For the generation and purification ... are packaged together for complete cDNA ... can be used for performing labeling ...
... CyScribe Post-Labeling Kit with CyScribe ... the generation and purification of Cy3- ... together for complete cDNA labeling and ... used for performing labeling reactions with ...
Biology Products: